Unveiling the Future: Cipla's Vision for Expanding Market Reach, Innovating with Semaglutide, and Navigating Regulatory Challenges | Umang Vohra ,CEO, Cipla Ltd. 00:10:00
This interview delves into Cipla's historical legacy, its current market position, and future strategies, including plans for introducing semaglutide in India, navigating regulatory challenges, and expanding market reach. The discussion also touches on succession planning, competition in the pharmaceutical industry, and the company's focus on maintaining quality standards amidst growth aspirations.
